GLENMARK PHARMACEUTICALS LTD. - Outcome of Operations Committee Meeting

Glenmark Pharmaceuticals Ltd has informed BSE that the Operations Committee of the Board of Directors of the Company, at its Meeting held on June 22, 2015 allotted 32,500 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.